Occudo Quantitative Strategies’s Whitehawk Therapeutics WHWK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-22,291
Closed -$89.4K – 1003
2026
Q1
$89.4K Buy
+22,291
New +$69.8K ﹤0.01% 714

Other funds holding WHWK

Occudo Quantitative Strategies's WHWK Position: Q2 2026 in Review

Occudo Quantitative Strategies sold out of Whitehawk Therapeutics (WHWK) in Q2 2026, closing a stake of 22,291 shares — an estimated $89.4K sold.

Occudo Quantitative Strategies first reported a position in WHWK in Q1 2026 and held it in 1 quarter. The position peaked at $89.4K in Q1 2026. 77 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • Occudo Quantitative Strategies reported no remaining Whitehawk Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 22,291 Whitehawk Therapeutics shares in Q2 2026, an estimated $89.4K.
  • Occudo Quantitative Strategies first reported a position in Whitehawk Therapeutics in Q1 2026 and held it in 1 quarter.
  • Occudo Quantitative Strategies's Whitehawk Therapeutics position peaked at $89.4K in Q1 2026.
  • 77 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.